| Date Posted |
Subject |
| Dec. 29, 2007 |
REACTIVATED DISCUSSION: Extraordinary
effort to accommodate requests for autologous and directed donations |
| Dec. 27, 2007 |
REACTIVATED DISCUSSION: Compliance
with the new requirements for labeling of aliquots and pooled components |
| Dec. 18, 2007 |
Assignment
of outdate for 5 day plasma ADDENDA Jan. 2, 2008 |
| Dec. 13, 2007 |
When
is additional RhIG required? ADDENDA Jan.
1, 9 & 25, 2008 |
| Dec. 12, 2007 |
REACTIVATED
DISCUSSION: Switching
from uncrossmatched type O to type-specific Red
Cells in urgent bleeding situations |
| Nov. 27, 2007 |
Induction of an inhibitor
antibody to factor XI in a patient with severe inherited factor XI
deficiency |
| Nov. 22, 2007 |
Strategies
to minimize the use of pre-transfusion blood specimens
that contain the wrong blood in the tube ADDENDA Nov. 24 |
| Nov. 22, 2007 |
REACTIVATED
DISCUSSION: QC
checks for ABO typing reagents; what
is required for compliance with rules/regulations
versus what is needed to assure test results are
accurate for patients who might need transfusion? |
| Nov. 15, 2007 |
How
to properly charge for antigen typing of donor units when trying
to find phenotype matched blood for a patient with multiple red cell
alloantibodies |
| Nov. 13, 2007 |
Extending
the expiration date of platelet products ADDENDA Nov.
15 |
| Nov. 13, 2007 |
REACTIVATED
DISCUSSION: 2,3-DPG
kits and reagents needed for red cell storage studies |
| Nov. 7, 2007 |
REACTIVATED DISCUSSION: What are the personnel
requirements for hanging blood components and signing off on the
transfusion records? |
| Nov. 3, 2007 |
Testing for viral infection
in donors using NAT |
| Nov. 3, 2007 |
Using
intraosseous (intramedullary) blood samples for pre-transfusion and
other testing |
| Nov.
3, 2007 |
REACTIVATED
DISCUSSION: Documentation
of blood component transportation from the hospital transfusion service
to the patient's location ADDENDA Nov.
3 |
| Oct. 22, 2007 |
What
is the “magic number” or percentage of patient records
that need to be verified when implementing a new
computer system in a blood bank? ADDENDA Oct.
27 & Dec. 4 |
| Oct.
17,
2007 |
Now
that California Senate Bill 'SB 250' has been signed
into law, will this create compliance problems
for donor collection centers that issue gift cards
as an incentive to the donor? ADDENDA Nov.
7 & 15 |
| Oct. 16, 2007 |
Blood
product recall for a donor testing positive in
an EIA for HIV antibodies but indeterminate in
an HIV-1 Western Blot and negative for HIV-1 RNA
by NAT ADDENDA Nov. 18 & 27 |
| Oct. 12, 2007 |
What
are expert thoughts about the recent articles on
Nitric Oxide and banked blood? |
| Oct. 11, 2007 |
REACTIVATED DISCUSSION: What
is the correct procedure for decommissioning an
outdated blood product irradiator? |
| Oct. 6, 2007 |
Can
cryoprecipitate-reduced plasma be converted to
thawed plasma and used within 5 days? ADDENDA Oct. 9 |
| Oct. 5, 2007 |
Managing
a patient with whose post partum blood specimen
tests positive in a rosette screening test for
fetal-maternal hemorrhage, but tests negative in
a Kleihauer-Betke (KB) or a flow cytometry test
for the presence of Hgb F containing red cells ADDENDA Oct. 15 |
| Oct. 1, 2007 |
Expiration
date for a 6% solution of albumin made from a commercially
prepared 22% solution of albumin ADDENDA Oct
2, 4 & 23 |
| Sept. 21, 2007 |
REACTIVATED DISCUSSION: Using
a microwave to thaw FFP ADDENDA Mar. 16, 2009 |
| Sept. 17, 2007 |
REACTIVATED
DISCUSSION: Is
it necessary to determine the specificity of HTLA
antibodies? ADDENDA Mar.
29 & 31; Sept. 17 & 20, 2007 |
| Sept. 17, 2007 |
Patient
'wallet card' text for HPA-1a antibodies ADDENDA Sept.
24 & Oct. 1 |
| Sept. 17, 2007 |
Practical
considerations when collecting "shed blood" into a disposable
system for blood reinfusion ADDENDA Sept.
17 & 21 |
| Aug. 31, 2007 |
REACTIVATED
DISCUSSION: Eligibility
for pre-operative autologous donation by brain
tumor patients who had a recent seizure ADDENDA Dec.
1, 2 & 3, 2003; Aug. 30, 2007 |
| Aug. 15, 2007 |
Use
of blood product labels that are peeled off of
printed transfusion forms (tags) ADDENDA Sept.
17 |
| July 31, 2007 |
Determining
the correct dosage of RHIG for immunoprophylaxis
of feto-maternal hemorrhage (FMH) ADDENDA Aug.
1, 2, 3, 5 & 10 |
| July 25, 2007 |
How
long must records be retained for deceased patients? ADDENDA July
30 |
| July 16, 2007 |
REACTIVATED DISCUSSION: Policies
for Ensuring An Adequate Supply of O Rh Negative
Blood in Emergencies Mar.
24, 2001; ADDENDA June 10, 2005; Mar.
2, 2006; Jan. 3, July 16 & 20, Aug. 10, 2007; June 13 & July 16, 2008 |
| July 11, 2007 |
Dispensing
blood products for neonates in a syringe and compliance
with ISBT labeling requirements ADDENDA July
12 & 16 |
| July 11, 2007 |
REACTIVATED
DISCUSSION: Protocols
for re-entry of blood donors who are HIV-1 EIA-reactive
but Western blot negative ADDENDA July
27 & Aug. 7 |
| July 11, 2007 |
Management
of donors who are repeat reactive on Treponema
pallidum specific antibody tests but non-reactive
on enzyme immunoassay or other fluorescent treponemal
antibody confirmatory tests ADDENDA July
27 & Aug 27 |
| July 9, 2007 |
REACTIVATED
DISCUSSION: Limitation
to new method for quantification of feto-maternal
haemorrhage (FMH) by flow cytometry with anti-fetal
haemoglobin ADDENDA July 11 |
| June 26, 2007 |
Irradiating all cellular products (RBC and Platelets)? ADDENDA June 27 |
| June 26, 2007 |
REACTIVATED DISCUSSION: Policies
defining when platelets and RBCs
should be cultured as part of a transfusion reaction investigation
Oct. 4, 2001; ADDENDA Oct 6 & 8, 2001;
Mar. 28, 2006; June 26, July 2 & 16, 2007 |
| June 22, 2007 |
Managing
neonates whose mothers have identified red cell
antibodies ADDENDA July 9 & 16 |
| June 19, 2007 |
Testing
to measure efficacy of a transfusion ADDENDA July 8 |
| June 19, 2007 |
Standardizing transfusion appropriateness |
| June 14, 2007 |
Experience with building ISBT component and modified component codes in older LIS systems ADDENDA June 26 |
| June 14, 2007 |
What
information is routinely available to blood bank
laboratories when blood products are requested
for transfusion? ADDENDA June
26 & July 17 |
| June 12, 2007 |
REACTIVATED DISCUSSION: Are
transfusion services in California utilizing
non-Clinical Laboratory Scientists (CLS) within
their laboratories, and if so, in what capacities? ADDENDA July
6 |
| June 11, 2007 |
REACTIVATED DISCUSSION: Monitoring vital signs during and after blood transfusion - revisited |
| June 4, 2007 |
When is it to appropriate to discontinue providing leukoreduced and irradiated cellular components for pediatric cardiac bypass patients after surgery? ADDENDA June 11 |
| May 31, 2007 |
'Decontamination' of cord blood collection bags before stem cell processing |
| May 30, 2007 |
REACTIVATED DISCUSSION: When the supernatant of a red cell unit shows visible discoloration suggesting hemolysis, should it be issued for transfusion? ADDENDA Mar. 4, 2008 |
| May 30, 2007 |
Provision of washed allogeneic packed RBCs for adult cardiovascular surgery ADDENDA June 5 |
| May 22, 2007 |
How are Transfusion Services documenting peer review of Medical Director competence? ADDENDA June 8 |
| May 22, 2007 |
Long-term storage of stem cells in the vapor phase of liquid nitrogen vs -80°C in a mechanical freezer |
| May 21, 2007 |
REACTIVATED DISCUSSION: How do collection centers or hospital blood banks manage post donation information events involving a diagnosis of cancer when the cancer diagnosis is made AFTER one or more previous blood donations? |
| May 16, 2007 |
REACTIVATED DISCUSSION: Maintaining inventories of plasma with low titer anti-T |
| May 13, 2007 |
Policies for providing red cells for trauma patients with multiple antibodies ADDENDA May 15, 22, 25 & 30 |
| May 2, 2007 |
Indications to perform a titer when anti-D is detected in a patient who has received Rh Immune Globulin ADDENDA May 4, 8 & 13 |
| Apr. 28, 2007 |
REACTIVATED DISCUSSION: Donor eligibility of a man who dresses as a woman in anticipation of sex change surgery ADDENDA May 22 |
| Apr. 25, 2007 |
Use of 'autologous serum eye drops' for patients with certain corneal disorders ADDENDA Apr. 27, May 2 & 4, June 1; Sept. 16, 2008 |
| Apr. 24, 2007 |
REACTIVATED DISCUSSION: How well do clinicians document the reasons for their order to transfuse a patient? ADDENDA May 13 & 25, June 1 |
| Apr. 21, 2007 |
REACTIVATED DISCUSSION: Donor deferral for taking medication Nov. 3, 2001; ADDENDA Nov. 12 & 21; Mar. 15 & 16, 2003; Jan. 14, Feb. 12 & Apr. 21, 2007 |
| Apr. 21, 2007 |
REACTIVATED DISCUSSION: Planning for a natural or man-made disaster at hospitals and blood centers ADDENDA Apr. 27 |
| Apr. 19, 2007 |
What are the requirements and practices of other blood centers in California for accepting 16-year old donors? ADDENDA June 22, 2008 |
| Apr. 19, 2007 |
What categories of personnel are being assigned to perform autologous and directed donations, and what categories of personnel are being assigned to perform therapeutic phlebotomies? |
| Apr. 15, 2007 |
REACTIVATED DISCUSSION: Which solutions other than isotonic saline are approved for addition to blood and components? ADDENDA Apr. 24 |
| Apr. 15, 2007 |
Are there data to support the practice of transfusing a 'trial' dose of platelets to patients with a presumptive diagnosis of ITP? ADDENDA Apr. 21 & 25 |
| Apr. 7, 2007 |
Backing up vital records "off site" ADDENDA Apr. 30 |
| Apr. 5, 2007 |
Using a computer program to assist in the identification of unexpected red cell antibodies ADDENDA Apr. 8, 14 & 16; May 25 & 29 |
| Apr. 4, 2007 |
Enzymatic removal of group A and group B antigens: how close are we to a universal blood supply? |
| Apr. 4, 2007 |
Unexpected, severe, life-threatening hyperkalemia during liver transplantation ADDENDA Apr. 14 |
| Apr. 4, 2007 |
Clogging of blood administration set filters ADDENDA Apr. 5 & 14 |
| Mar. 30, 2007 |
Are institutions following the recommendation that women, regardless of inital Rh type, be tested at least twice for RhD during their first pregnancy? |
| Mar. 28, 2007 |
REACTIVATED DISCUSSION: How long may a primed ECLS/ECMO circuit run without a patient connected? ADDENDA July 16, 2003; Mar. 28, 2007 |
| Mar. 25, 2007 |
REACTIVATED DISCUSSION: Reconciling conflicting results for Rh typing using different test reagents ADDENDA Feb. 4 & 5, 2003; Mar. 25, 2007; June 11, 2008 |
| Mar. 23, 2007 |
Are Transfusion Services billing separately for FFP thawing? |
| Mar. 23, 2007 |
Report of anaphylactic-type reactions seemingly associated with 7-day platelet products |
| Mar. 21, 2007 |
A proposal to eliminate weak D testing on autologous RBC donations |
| Mar. 21, 2007 |
Disposition of recombinant Factor VIIa (rFVIIa) that has been dispensed for patient use, but returned unused ADDENDA Mar. 27 |
| Mar. 15, 2007 |
REACTIVATED DISCUSSION: Routine cord blood serologic testing - Who needs it? Aug. 14, 2001; ADDENDA Aug. 15 & 17; Dec. 1, 2001; July 5 & Aug. 7, 2003;Mar. 15, 2007 |
| Mar. 15, 2007 |
REACTIVATED DISCUSSION: Survey
on Informed Consent for Transfusion Aug. 24, 2003; ADDENDA Aug.
25, 26, 28, 30 & Sept. 1, 2003; Feb. 9 & Mar. 15 & 17,
2007; Jan. 29 & Oct. 24, 2008 |
| Mar. 13, 2007 |
Corrective actions for mistakenly reporting an incompatible RBC donor unit as crossmatch compatible when it is not ADDENDA Mar. 19 |
| Mar. 1, 2007 |
REACTIVATED DISCUSSION: Experience in the use of THAWED PLASMA Mar. 21, 2005; ADDENDA Mar. 21, 22, 23 & Apr. 3, 2005; Mar. 1, 6, 7 & 17, 2007 |
| Feb. 26, 2007 |
REACTIVATED DISCUSSION: Practical concerns regarding the location of a hospital blood bank away from the operating rooms June 28, 2004; ADDENDA June 29 & July 8, 2004; Feb. 26, 2007 |
| Feb. 26, 2007 |
REACTIVATED DISCUSSION: What is an effective strategy to assure that a blood product dispensed via a pneumatic tube system is administered to the correct recipient? Mar. 28, 2005; ADDENDA Sept. 12 & 18, 2006; Feb. 26, 2007 |
| Feb. 21, 2007 |
Blood component description on unit tag and transfusion record ADDENDA Feb. 23, 26 & 27; Mar. 6 |
| Feb. 21, 2007 |
REACTIVATED DISCUSSION: Transfusing donor RBC units obtained from individuals whose plasma contains unexpected antibodies May 1, 2002; ADDENDA May 2, 2002; Feb. 21, 2007; May 16, 2008 |
| Feb. 19, 2007 |
Comments
requested on Joint Commission meeting to determine
the need to incorporate blood management performance
measures into their survey and accreditation
process ADDENDA Feb.
20 & Mar.
17; July 25, 30 & 31, Aug. 12, 17, 21 & 22, 2008 |
| Feb. 19, 2007 |
REACTIVATED DISCUSSION: Should at-risk donors be interviewed and/or tested for T. cruzi infection to prevent transfusion-transmitted Chagas Disease? June 11, 2002; ADDENDA June 12 & 21; July 11; Aug. 1; Sept. 3; Nov 29 & 30, 2004; Feb. 19, 21 & 24, 2007 |
| Feb. 15, 2007 |
REACTIVATED DISCUSSION: Validating igloo coolers that are used to 'store' blood in the operating room May 29, 2002; ADDENDA Feb. 15, 2007 |
| Feb. 13, 2007 |
Using bar codes to link blood products to the correct recipient: Is using a bar code that only encodes a single number a compliant and a safe practice? |
| Feb. 9, 2007 |
Importance of language: Plasmapheresis vs plasma exchange ADDENDA Feb. 20 |
| Feb. 5, 2007 |
REACTIVATED DISCUSSION: Monitoring temperature of blood products transported within the hospital Sept. 12, 2002; ADDENDA Sept. 14, 16 & 18; May 12, 22 & 24, 2006; Feb. 5 & 15, 2007 |
| Feb. 5, 2007 |
How cold must human antiserum be stored? ADDENDA Feb. 19 |
| Jan. 26, 2007 |
REACTIVATED DISCUSSION: What do blood collection centers do with donors who are implicated in TRALI, and those whose blood is at high risk of causing TRALI? Jan. 7, 2004; ADDENDA July 30, 2004; June 3, 2005; Nov. 15, 2006; Jan. 26 & 29; Feb. 5 & 26, 2007 |
| Jan. 22, 2007 |
REACTIVATED DISCUSSION: Risk of hyperkalemia from irradiated Red Cells used to prime ECMO circuits in neonates Nov. 29, 2004; ADDENDA Jan. 11 & 14, 2005; Jan. 22, 2007 |
| Jan. 16, 2007 |
REACTIVATED DISCUSSION: Is simultaneous crossmatching of multiple patients by the same technologist permissible under current JCAHO requirements? Feb. 16, 2003; ADDENDA Feb. 17, 2003; Jan. 16, 2007 |
| Jan. 14, 2007 |
Strategies for transfusion support of a patient with TAR (Thrombocytopenia Absent Radius) Syndrome ADDENDA Jan. 24 |
| Jan. 13, 2007 |
When considering Rh immunoprophylaxis for an Rh negative woman, if a test for D on her newborn baby is negative, what methods are used to rule out the possibility that the newborn has a "Weak D" phenotype? ADDENDA Feb. 13; Mar. 27, 2008 |
| Jan. 12, 2007 |
Comments requested on documents for the use of ISBT 128 for coding and labeling of cellular therapy products |
| Jan. 9, 2007 |
Medicare
reimbursement policy for pre-operative use of
erythropoietin to optimize hemoglobin prior to
elective surgery ADDENDA Jan.
15 & 26; Oct. 6 |
| Jan. 3, 2007 |
REACTIVATED DISCUSSION: When Red Cells are dispensed in a syringe, what is their expiration? Sept. 24, 2000; ADDENDA Jan. 3, 4 & 5, 2007 |
| Jan. 2, 2007 |
Data or experience to support the use of plasma exchange in anti-GBM negative, ANCA negative pauci-immune RPGN |
| Jan. 2, 2007 |
Fluid replacement practices in plasma exchange when FFP alone is not indicated |
Back to Top 
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
